Ten consecutive children with high risk leukemia have been submitted to UCB transplant from unrelated HLA mismatched donors. All patients received an identical regimen for conditioning and GVND prophylaxis. The median dose of viable nucleated cells infused was 2.6 x 106/kg b.w. Among the nine patients evaluable for engraftment the hematopoiesis was of full donor origin in six patients and autogolous in three. At a median follow-up of 9 months, six of nine (67%) patients are alive in CR.
|Journal||Bone Marrow Transplantation|
|Issue number||SUPPL. 1|
|Publication status||Published - 1998|
- Cord blood transplant
- Unrelated mismatched transplant
ASJC Scopus subject areas